RYMDX | UOPIX | RYMDX / UOPIX | |
Total Expense Ratio | 1.71 | 1.53 | 112% |
Annual Report Gross Expense Ratio | 1.82 | 1.53 | 119% |
Fund Existence | 24 years | 27 years | - |
Gain YTD | -11.375 | -15.741 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 15000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.9M | 901M | 1% |
Annual Yield % from dividends | 0.84 | 0.50 | 167% |
Returns for 1 year | -6.30 | 6.87 | -92% |
Returns for 3 years | 21.92 | 80.58 | 27% |
Returns for 5 years | 70.72 | 114.46 | 62% |
Returns for 10 years | 77.88 | 511.58 | 15% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DSTL | 53.05 | 0.38 | +0.72% |
Distillate US Fdmtl Stblty & Val ETF | |||
FMED | 23.41 | 0.12 | +0.52% |
Fidelity Disruptive Medicine ETF | |||
HPS | 14.45 | 0.06 | +0.42% |
John Hancock Preferred Income Fund III | |||
PZC | 6.39 | -0.06 | -0.93% |
PIMCO California Municipal Income Fund III | |||
IPOS | 13.53 | -0.20 | -1.49% |
Renaissance International IPO ETF |